Clinical Trials · NCT03970044
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Consano Clinical Research, LLC
- Enrollment
- 67
- Start date
- Jul 2019
- Locations
- 1 site, United States
- Primary endpoint
- MAGE